Hambro Perks Acquisition said in a statement that it had ceased all operations except for the purposes of winding up the company and returning money to shareholders, The Guardian reports.
Sir Anthony Salz, the chair of the tech investment company, blamed “challenging circumstances” for stock market listings.
In autumn 2021 Hambro Perks said it had raised £143.5 million ($178 million) from the stock market to find an investment target, slightly shy of the £150 million ($186 million) it had hoped for. However, Salz said the company would probably be unable to find a suitable target for acquisition before the end of a two-year deadline in November, after talks fell through this year with the drug developer Istesso. Read more.
Source: First SPAC set up Under New UK Rules to Close After Failing to Find Merger Target